Chronická lymfatická leukemie
- MUDr. Lukáš Smolej, 2. Interní klinika - oddělení klinické hematologie, FN Hradec Králové
- prof. MUDr. Jiří Mayer, CSc., Interní hematoonkologická klinika FN Brno, Brno
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
Otevřít | 2016 | MUDr. Lucie Němcová
Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia
Otevřít | 2015 | MUDr. Jakub Trizuljak
Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia
Otevřít | 2010 | MUDr. Anna Panovská
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia
Otevřít | 2009 | MUDr. Anna Panovská
Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
Otevřít | 2008 | MUDr. František Folber
Trends in long-term survival of patients with chronic lymfocytic leukemia from the 1980s to the early 21st century
Otevřít | 2008 | MUDr. Anna Panovská
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia
Otevřít | 2008 | MUDr. Anna Panovská
Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia
Otevřít | 2008 | MUDr. František Folber
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International workshop on chronic lymphocytic leukemia updating the National cancer institute-working group 1996 guidelines
Otevřít | 2008 | MUDr. František Folber
Fludarabin s cyklofosfamidem versus fludarabin v monoterapii jako léčba 1. linie u mladších nemocných s chronickou lymfocytární leukémií (studie CLL-4).
Otevřít | 2008 | MUDr. Lukáš Smolej
Alemtuzumab versus chlorambucil jako léčba 1. linie u chronické lymfocytární leukémie (studie CAM307)
Otevřít | 2008 | MUDr. Lukáš Smolej, Ph.D.
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia ( the LRF CLL4 Trial): a randomised controlled trial
Otevřít | 2007 | MUDr. Yvona Brychtová